Published in J Rheumatol Suppl on June 01, 1987
C5a alters blood-brain barrier integrity in experimental lupus. FASEB J (2010) 1.06
Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism. J Immunol (2012) 0.95
Inhibition of C5a receptor alleviates experimental CNS lupus. J Neuroimmunol (2010) 0.85
C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus. Immunology (2015) 0.76
C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus. Immunology (2016) 0.75
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest (1975) 6.25
Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement. Proc Natl Acad Sci U S A (1973) 4.58
The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J Exp Med (1977) 4.44
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34
Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes. J Cell Biol (1968) 4.22
Effect of cyclic AMP on release of lysosomal enzymes from phagocytes. Nat New Biol (1971) 4.09
Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J Clin Invest (1974) 3.65
Cytochalasin B: effect on lysosomal enzyme release from human leukocytes. Proc Natl Acad Sci U S A (1973) 3.63
Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia (2009) 3.40
Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles. J Exp Med (1971) 3.38
Release of inflammatory mediators from stimulated neutrophils. N Engl J Med (1980) 3.35
Calcium-induced lysozyme secretion from human polymorphonuclear leukocytes. Biochem Biophys Res Commun (1974) 3.24
Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med (1990) 3.23
A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1992) 2.79
Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation. J Immunol (1973) 2.66
Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J (1999) 2.50
Lysosome. N Engl J Med (1965) 2.49
The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest (1973) 2.42
Changes in membrane potential of human granulocytes antecede the metabolic responses to surface stimulation. Proc Natl Acad Sci U S A (1978) 2.33
Mechanisms of lysosomal enzyme release from human leukocytes. I. Effect of cyclic nucleotides and colchicine. J Cell Biol (1973) 2.33
Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med (1991) 2.32
Interaction of alytic polypeptide, melittin, with lipid membrane systems. J Biol Chem (1969) 2.31
Effect of cyclic 3',5'-adenosine monophosphate and theophylline on lymphocyte transformation. Proc Soc Exp Biol Med (1970) 2.30
Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun (1986) 2.27
Leukocytic proteases and the immunologic release of lysosomal enzymes. Am J Pathol (1972) 2.26
Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med (1983) 2.18
Potassium and amino acid transport in human leukocytes exposed to phagocytic stimuli. J Cell Biol (1974) 2.16
Effects of cholera enterotoxin on adenosine 3',5'-monophosphate and neutrophil function. Comparison with other compounds which stimulate leukocyte adenyl cyclase. J Clin Invest (1973) 2.16
The action of steroids and streptolysin S on the permeability of phospholipid structures to cations. J Mol Biol (1965) 2.10
Concanavalin A induces microtubule assembly and specific granule discharge in human polymorphonuclear leukocytes. J Cell Biol (1976) 2.08
Psychiatric referral from a general practice. Br J Psychiatry (1969) 2.04
A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol (1999) 2.04
Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J Immunol (1974) 2.02
Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro. Biochem Biophys Res Commun (1982) 2.02
Classification and definition of major flares in SLE clinical trials. Lupus (1999) 2.02
Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi. Mucosal Immunol (2009) 2.01
Breakdown of cartilage proteinpolysaccharide by lysosomes. Arthritis Rheum (1968) 1.99
Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol (1985) 1.96
Lysosomes and joint disease. Arthritis Rheum (1966) 1.90
Phospholipid spherules (liposomes) as a model for biological membranes. J Lipid Res (1968) 1.89
Mechanisms of lysosomal enzyme release from human polymorphonuclear leukocytes. Effects of phorbol myristate acetate. J Cell Biol (1975) 1.87
Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation (1999) 1.85
Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol (1992) 1.84
Stimulus response coupling in the human neutrophil. II. Temporal analysis of changes in cytosolic calcium and calcium efflux. J Biol Chem (1984) 1.84
Ceruloplasmin. A scavenger of superoxide anion radicals. J Biol Chem (1979) 1.84
The adhesion molecules of inflammation. Arthritis Rheum (1993) 1.83
Lysosomal mechanisms of tissue injury in arthritis. N Engl J Med (1972) 1.81
A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet (1989) 1.80
The role of lysosomes in inflammation and disease. Annu Rev Med (1967) 1.76
Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest (1986) 1.76
A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells. Proc Natl Acad Sci U S A (1975) 1.76
Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol (1978) 1.76
Degranulation, membrane addition, and shape change during chemotactic factor-induced aggregation of human neutrophils. J Cell Biol (1982) 1.75
The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med (1987) 1.73
Carboxyl methylation of Ras-related proteins during signal transduction in neutrophils. Science (1993) 1.72
Proposal for a new definition of congenital complete atrioventricular block. Lupus (2003) 1.70
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA (1999) 1.70
Role of microtubule assembly in lysosomal enzyme secretion from human polymorphonuclear leukocytes. A reevaluation. J Cell Biol (1977) 1.69
Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis. Biochem Biophys Res Commun (1982) 1.69
Reciprocal effects of cAMP and cGMP on microtubule-dependent release of lysosomal enzymes. Ann N Y Acad Sci (1975) 1.68
B-cell alloantigen Ag 7a in multiple sclerosis. Lancet (1975) 1.67
The action of polyene antibiotics on phospholipid-cholesterol structures. J Biol Chem (1967) 1.67
The roles of extracellular and intracellular calcium in lysosomal enzyme release and superoxide anion generation by human neutrophils. Biochim Biophys Acta (1981) 1.65
Crystal deposition disease. Diagnosis by electron microscopy. Am J Med (1977) 1.63
The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum (1989) 1.63
Incorporation of lysozyme into liposomes. A model for structure-linked latency. J Biol Chem (1970) 1.62
Sudden blindness in acute pancreatitis. Possible role of complement-induced retinal leukoembolization. Arch Intern Med (1981) 1.62
Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum (2000) 1.61
Molecular basis of gouty inflammation: interaction of monosodium urate crystals with lysosomes and liposomes. Nat New Biol (1972) 1.59
Phosphatidate and oxidized fatty acids are calcium ionophores. Studies employing arsenazo III in liposomes. J Biol Chem (1981) 1.59
Studies on lysosomes. XII. Redistribution of acid hydrolases in human lymphocytes stimulated by phytohemagglutinin. J Cell Biol (1968) 1.58
Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative. Am J Transplant (2012) 1.57
A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med (1990) 1.57
Thromboxane generation by human peripheral blood polymorphonuclear leukocytes. J Exp Med (1978) 1.57
Dissociation between increased surface expression of gp165/95 and homotypic neutrophil aggregation. J Immunol (1988) 1.56
Enterococcal arthritis with avascular necrosis in a lupus patient. Br J Rheumatol (1996) 1.55
Arthritis induced in rabbits by lysates of granulocyte lysosomes. Arthritis Rheum (1969) 1.55
Stimulus response coupling in the human neutrophil. I. Kinetic analysis of changes in calcium permeability. J Biol Chem (1984) 1.52
C-reactive protein in systemic lupus erythematosus. Arthritis Rheum (1977) 1.52
The role of lysosomes in immune responses. Adv Immunol (1970) 1.47
Characterization of a neutral protease from lysosomes of rabbit polymorphonuclear leucocytes. Biochem J (1971) 1.45
Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes. Biochem Pharmacol (1980) 1.44
Enhancement of nitroblue tetrazolium dye reduction by leukocytes exposed to a component of complement in the absence of phagocytosis. J Immunol (1975) 1.43
Influence of divalent cations upon complement-mediated enzyme release from human polymorphonuclear leukocytes. J Immunol (1975) 1.43
Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proc Natl Acad Sci U S A (1991) 1.43
Up-regulation of the iC3b receptor (CR3) is neither necessary nor sufficient to promote neutrophil aggregation. J Clin Invest (1988) 1.42
CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice. Proc Natl Acad Sci U S A (2001) 1.41
Who should do psychotherapy? Br Med J (1970) 1.38
Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem (1996) 1.37
Receptors for IgM on certain human B lymphocytes. J Immunol (1977) 1.37
Increased levels of cyclic adenosine-3',5'-monophosphate in human polymorphonuclear leukocytes after surface stimulation. J Clin Invest (1980) 1.36
Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production. J Exp Med (1977) 1.36
Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci U S A (1999) 1.36
Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest (1989) 1.36
Stimulus-response coupling in the human neutrophil. Transmembrane potential and the role of extracellular Na+. Biochim Biophys Acta (1980) 1.35
Appearance of hydrolase rich granules in human lymphocytes induced by phytohemagglutinin and antigens. Blood (1967) 1.35